Skip to main content
Year archive

Marinomed Biotech AG — 2026 filings

All 32 regulatory filings released by Marinomed Biotech AG (MARI) in 2026, sourced directly from the official regulator.

32 Filings
2026 Period
2026 filings (32)
Filing Released Lang
Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv Technology in Inhalation Therapy
Regulatory Filings
2026-05-19 English
EQS-AGM: Marinomed Biotech AG: Invitation to the 9th Annual General Meeting on Thursday, June 11, 2026, at 13:00 (Vienna time)
Proxy Solicitation & Information Statement
2026-05-13 English
EQS-HV: Marinomed Biotech AG: Einberufung der 9. ordentlichen Hauptversammlung für Donnerstag, den 11. Juni 2026 um 13:00 Uhr (Wiener Zeit)
Proxy Solicitation & Information Statement
2026-05-13 German
Marinomed Biotech AG: Invitation to the 9th Annual General Meeting on Thursday, June 11, 2026, at 13:00 (Vienna time)
Proxy Solicitation & Information Statement
2026-05-13 English
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Regulatory Filings
2026-05-11 English
EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2026-04-30 English
EQS-NVR: Marinomed Biotech AG: Veröffentlichung der Gesamtstimmrechte nach § 135 Abs. 1 BörseG mit dem Ziel der europaweiten Verbreitung
Declaration of Voting Results & Voting Rights Announcements
2026-04-30 German
Release according to Article 135, Section 1 BorseG with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2026-04-30 English
EQS-AFR: Marinomed Biotech AG: Release of a Financial report
Annual Report FY 2025
2026-04-22 German
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines Finanzberichtes
Annual Report FY 2025
2026-04-22 German
Report Publication Announcement 2026
Report Publication Announcement
2026-04-22 English
EQS-AFR: Marinomed Biotech AG: Release of a Financial report
Annual Report FY 2025
2026-04-22 English
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines Finanzberichtes
Annual Report FY 2025
2026-04-22 German
EQS-DD: Marinomed Biotech AG: Eva Prieschl-Grassauer, buy
Director's Dealing
2026-04-15 English
EQS-DD: Marinomed Biotech AG: Eva Prieschl-Grassauer, Kauf
Director's Dealing
2026-04-15 German
Marinomed Biotech AG: Eva Prieschl-Grassauer, buy
Director's Dealing
2026-04-15 English
EQS-DD: Marinomed Biotech AG: Andreas Grassauer, buy
Director's Dealing
2026-04-15 English
EQS-DD: Marinomed Biotech AG: Andreas Grassauer, Kauf
Director's Dealing
2026-04-15 German
Marinomed secures financing through successful capital increase
Share Issue/Capital Change
2026-04-13 English
EQS-DD: Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing
2026-03-31 German
Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing
2026-03-31 German
EQS-DD: Marinomed Biotech AG: Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
Director's Dealing
2026-03-31 German
Release according to Article 95a, Section 5 AktienG with the objective of Europe-wide distribution
Director's Dealing
2026-03-30 German
EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
Capital/Financing Update
2026-03-19 English
EQS-Adhoc: Marinomed Biotech AG beschließt Barkapitalerhöhung zur Deckung eines kurzfristigen Kapitalbedarfs iHv rund EUR 2 Millionen
Share Issue/Capital Change
2026-03-19 German
Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
Capital/Financing Update
2026-03-19 English